# Eli Lilly's biggest shareholder selling $347m stock

> Lilly Foundation's $347m stock sale won't hurt your investment.
- Title: Eli Lilly's biggest shareholder selling $347m stock | Shortify
- Summary: Lilly Foundation's $347m stock sale won't hurt your investment. Lilly shareholders shouldn't sell after largest shareholder's annual charity payout.
- Keywords: eli lilly, lilly foundation, mounjaro, zepbound, glp-1 drugs, stock sale, finance, money, Eli, Lilly's, biggest, shareholder
- Source: The Motley Fool — https://fool.com/investing/2026/10/16/eli-lillys-biggest-shareholder-is-selling-347-mill
- Author: Matthew Benjamin
- Published: 2026-10-16T11:10:00+00:00
- Read time: 1 min
- Topics: eli lilly, lilly foundation, mounjaro, zepbound, glp-1 drugs, stock sale, finance, money
## Lilly Foundation's $347m stock sale
The largest shareholder of Eli Lilly is selling 300,000 shares worth $347 million.
## Annual charity payout
The sale is a required annual charity payout from the tax-exempt Lilly Foundation, not bearish activity.
## GLP-1 drug dominance
Lilly's Mounjaro and Zepbound are the world's best-selling drugs, dominating the $190 billion GLP-1 market.
## Key takeaway

Lilly shareholders shouldn't sell after largest shareholder's annual charity payout.